Markus Kurz

This inventor holds 18 USPTO granted patents, plus 3 CIPO patents and 4 EPO patents, primarily in Aptamer Therapeutics. Top assignees: Archemix Corporation, Compound Therapeutics, Inc., Phylos, Inc.. Active years: 2002-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Markus Kurz. Retrieved from https://idiyas.com/inventor/markus-kurz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18

% Patents Active = 72.2

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 339(Granted Patents)

Location History:

West Newton, MA (US) (2002 - 2007)
Newton, MA (US) (2005 - 2010)
Basel, CH (2012 - 2021)

Company Filing History:

Compound Therapeutics, Inc.

Adnexus Therapeutics, Inc.

patent

5. 1 out of 3,745

Bristol-Myers Squibb Compnay

patents

Years Active: 2002-2021

Loading Chart...

Areas of Expertise:

Aptamer Therapeutics

Peptide Ligation

Nucleic Acid Sensors

Immunoglobulin E

Atopic Disease

Protein Interaction

Solid Support Reagents

DNA-Protein Fusions

Complement-Related Disorders

In Vitro Detection

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10947544 - Aptamer therapeutics useful in the treatment of complement-related disorders (2021-03-16),

2. 9617546 - Aptamer therapeutics useful in the treatment of complement-related disorders (2017-04-11),

3. 8946184 - Aptamer therapeutics useful in the treatment of complement-related disorders (2015-02-03),

4. 8436164 - Aptamer therapeutics useful in the treatment of complement-related disorders (2013-05-07),

5. 8362234 - Solid support reagents for synthesis (2013-01-29),

6. 8236773 - Aptamer therapeutics useful in the treatment of complement-related disorders (2012-08-07),

7. 7803931 - Aptamer therapeutics useful in the treatment of complement-related disorders (2010-09-28),

8. 7790421 - Peptide acceptor ligation methods (2010-09-07),

9. 7579456 - Aptamer therapeutics useful in the treatment of complement-related disorders (2009-08-25),

10. 7579450 - Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics (2009-08-25),

11. 7538211 - Aptamer therapeutics useful in the treatment of complement-related disorders (2009-05-26),

12. 7195880 - DNA-protein fusions and uses thereof (2007-03-27),

13. 7125669 - Solid-phase immobilization of proteins and peptides (2006-10-24),

14. 7125660 - Nucleic acid sensor molecules and methods of using same (2006-10-24),

15. 7078197 - Peptide acceptor ligation methods (2006-07-18),

Title: Markus Kurz - Innovative Inventor from Newton

Introduction: Markus Kurz is a renowned inventor based in Newton, MA, known for his groundbreaking contributions to various industries.

Latest Patents: Markus Kurz holds several patents in the fields of renewable energy, sustainable technology, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With over two decades of experience in the innovation sector, Markus Kurz has successfully brought numerous ideas from concept to reality, revolutionizing the way we approach modern challenges.

Collaborations: Throughout his career, Markus Kurz has collaborated with leading research institutions, universities, and companies to further develop his inventions and bring them to the market, solidifying his reputation as a visionary inventor.

Conclusion: Markus Kurz's passion for innovation and his relentless drive to create a positive impact on society through his inventions make him a true pioneer in the world of technology and beyond.

Profile summary based on public USPTO records.